Staging and Monitoring of Small Cell Lung Cancer Using [18F]Fluoro-2-deoxy-D-glucose-Positron Emission Tomography (FDG-PET)
暂无分享,去创建一个
William Spies | Athanassios Argiris | A. Argiris | W. Spies | W. Gooding | William Gooding | Victoria Kut | Stewart Spies | V. Kut | S. Spies
[1] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[2] Jeffrey D Bradley,et al. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Larson,et al. Prognostic value of [18F]FDG-PET imaging in small cell lung cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[4] G. V. von Schulthess,et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. , 1998, The Annals of thoracic surgery.
[5] D. Ball,et al. Impact of Positron Emission Tomography on the Management of Patients With Small-Cell Lung Cancer: Preliminary Experience , 2004, American journal of clinical oncology.
[6] N. Saijo,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M Van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.
[8] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[9] Matthias T Wyss,et al. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[11] H. Groen,et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.
[12] M. Zelen. Keynote address on biostatistics and data retrieval. , 1973, Cancer chemotherapy reports. Part 3.
[13] P. Rigo,et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer , 1998, European Journal of Nuclear Medicine.
[14] R. Hustinx,et al. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. , 1997, The European respiratory journal.
[15] A. Argiris,et al. Progress in the therapy of small cell lung cancer. , 2004, Critical reviews in oncology/hematology.
[16] A. Argiris,et al. Staging and clinical prognostic factors for small-cell lung cancer. , 2001, Cancer journal.
[17] M. Mix,et al. FDG-PET imaging for the staging and follow-up of small cell lung cancer , 2001, European Journal of Nuclear Medicine.
[18] E. Stoelben,et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[19] J Kotzerke,et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] L. Adler,et al. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study. , 2002, Lung cancer.
[21] H. Steinert,et al. Whole-Body 18F-FDG PET Improves the Management of Patients with Small Cell Lung Cancer , 2003 .
[22] N. Dewan,et al. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. , 1997, Chest.